drugset / Trial / NCT00734929

Aprepitant With Dexamethasone Versus Ondansetron With Dexamethasone for PONV Prophylaxis in Patients Having Craniotomy

NCT00734929

Phase 4 Completed 115 enrolled Duke University Merck Sharp & Dohme LLC · collab
RandomizedParallel-groupQuadruple-blindPrevention

Summary

We hypothesize that the combination of aprepitant with dexamethasone will provide significantly improved prophylaxis against Postoperative nausea and vomiting compared with the combination of ondansetron and dexamethasone, in patients undergoing craniotomy under general anesthesia.

Timeline

Start
2007-09
Primary completion
2009-06
Completion
2009-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Aprepitant Other / unclassified 40 mg Oral
Comparator Ondansetron Other / unclassified 4 mg Intravenous
Comparator Dexamethasone Small molecule 10 mg

Indications

No indication recorded.